CSPC Pharmaceutical Group (1093)
5.84 HKD -0.37 (-5.96%) Volume: 307.18M
CSPC Pharmaceutical Group’s stock price is currently trading at 5.84 HKD, witnessing a decrease of -5.96% this trading session with a high volume of 307.18M trades, however, it boasts a positive Year-to-Date (YTD) percentage change of +22.18%, highlighting its strong market performance.
Latest developments on CSPC Pharmaceutical Group
Today, CSPC Pharmaceutical Group saw a significant increase in its stock price following the announcement of positive clinical trial results for its latest drug. The company’s stock had been steadily rising in the days leading up to this news, fueled by anticipation and speculation within the market. Investors were closely watching CSPC Pharmaceutical Group as it continued to expand its product pipeline and make strategic partnerships in the pharmaceutical industry. This surge in stock price reflects growing confidence in the company’s potential for future growth and success.
A look at CSPC Pharmaceutical Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, CSPC Pharmaceutical Group has a positive long-term outlook. With high scores in Dividend and Momentum, the company is showing strong performance in these areas. Additionally, its Value and Resilience scores indicate stability and potential for growth. While its Growth score is slightly lower, the overall outlook for CSPC Pharmaceutical Group appears to be promising.
CSPC Pharmaceutical Group Limited, a company that manufactures and sells pharmaceutical products, is positioned well for the future according to the Smartkarma Smart Scores. With a focus on vitamin C, antibiotics, and generic drugs, as well as the development of innovative drugs, the company has a diverse product portfolio. Its strong scores in Dividend and Momentum reflect its stability and growth potential, making CSPC Pharmaceutical Group a company to watch in the pharmaceutical industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
